Business Wire

Pernod Ricard to Integrate Malibu-Kahlúa International Brands into the Absolut Company on July 1st, 2009

Share
PERNOD-RICARD

Pernod Ricard to Integrate Malibu-Kahlúa International Brands into the Absolut Company on July 1 st , 2009

Regulatory News:

Following the successful acquisition of Allied Domecq in 2005 and since its creation in 2006, Malibu-Kahlúa International (MKI), a subsidiary of Pernod Ricard (Paris:RI), has created strong marketing foundations for Malibu, and its two liqueur brands Kahlúa and Tia Maria.

Malibu is the number one coconut-flavoured rums in the world, sold in more than 150 countries. Kahlúa and Tia Maria are the Group two coffee liqueurs, Kahlúa being the world’s leader in its category.

Recognizing the need to significantly increase the level of support behind these dynamic brands and to maximise efficiency, Pernod Ricard has decided to leverage the resources of The Absolut Company (TAC), the Swedish subsidiary in charge of the leading brand of Premium Vodka, Absolut, which offers many synergies.

As a result, the Malibu-Kahlúa International brands will be consolidated within The Absolut Company and will be managed out of Stockholm, Sweden effective with the new fiscal year 2009/10, July 1st , 2009.

About Pernod Ricard

Created by the merger of Pernod and Ricard (1975), the Group has undergone sustained development, based on both organic growth and acquisitions. The purchase of part of Seagram (2001), the acquisitions of Allied Domecq (2005) and recently of Vin & Sprit (2008) have made Pernod Ricard the world’s co-leader in wines and spirits with sales of € 6,589 million in 2007/08.
Pernod Ricard holds one of the most prestigious brand portfolios in the sector: ABSOLUT Premium Vodka, Ricard pastis, Ballantine’s, Chivas Regal and The Glenlivet Scotch whiskies, Jameson Irish Whiskey, Martell cognac, Havana Club rum, Beefeater gin, Kahlúa and Malibu liqueurs, Mumm and Perrier-Jouët champagnes, as well Jacob’s Creek and Montana wines.
The Group favours a decentralised organisation, with 7 Brand Owners and 70 Distribution Companies established in each key market, and employs a workforce of more than 19,300 people.
Pernod Ricard is strongly committed to a sustainable development policy and encourages responsible consumption.
Pernod Ricard is listed on the NYSE Euronext exchange (Ticker: RI; ISIN code: FR0000120693) and is a member of the CAC 40 index.

Shareholders’ agenda: 2008/09 3rd Quarter sales– Thursday 30 April 2009

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact:

Pernod Ricard
Francisco de la VEGA / Communication VP
Tel: +33 (0)1 41 00 40 96
or
Florence TARON / Press Relations Manager
Tel: +33 (0)1 41 00 40 88
or
Denis FIEVET / Financial Communication - Investor Relations VP
Tel: +33 (0)1 41 00 41 71

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Dow Launches DOWSIL™ EG-4175 Silicone Gel to Enable Higher Voltage Power Electronics in Electric Vehicles and Renewable Energy Technologies4.9.2025 11:00:00 CEST | Press release

This innovative silicone gel resists temperatures up to 180°C for Generation 7 IGBT modules Dow (NYSE: Dow) launched today DOWSIL™ EG-4175 Silicone Gel, a highly reliable protective solution for next-generation insulated gate bipolar transistor (IGBT) modules that operate at higher voltages. This new advanced material resists the higher temperatures associated with these IGBTs and supports greater reliability, lower power losses and higher power efficiencies in electric vehicle (EV) batteries and inverters for photovoltaic (PV) panels and wind turbines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904309932/en/ DOWSIL™ EG-4175 Silicone Gel is a protective solution, for next-generation insulated gate bipolar transistor (IGBT) modules, that withstands temperatures up to 180°C. This innovative gel from Dow supports greater reliability, lower power losses and higher power efficiencies in high-voltage power electronics for e

Ant International’s Antom Debuts Agentic Payment Solution, Pioneering APM Checkout Solution and Trusted AI for Secure Transactions4.9.2025 10:36:00 CEST | Press release

First to partner with Mastercard, Visa and leading wallets in Asia Pacific to accelerate real-world adoptionUnique in supporting both alternative payment method (APM) and credit card-based agentic payments through partnerships with global leadersProtocol introduces an industry-leading payment mandate model and risk management technologies for AI agents Antom, a leading merchant payment and digitisation services provider under Ant International, today announced the launch of an agentic payment solution, featuring a first-of-its-kind secure APM checkout solution. Antom is also among the first partners of Mastercard and Visa to pilot card-based transaction capabilities for AI agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903092575/en/ Antom's agentic payment solution supports diverse payment options with enhanced risk management for AI agents In a commercial setting, one of the most critical capabilities for AI agen

Belkin Introduces High-Speed Charging Solutions and Easy Audio Designed for Modern Living4.9.2025 10:00:00 CEST | Press release

Belkin International can be found on the IFA show floor, Exhibit Hall 3.2, stand #115 Belkin, a leading consumer electronics brand for over 40 years, today announced three new charging solutions, further expanding its award-winning mobile power portfolio, alongside four new additions to its growing SoundForm audio range. The newly announced products will debut at IFA 2025, where Belkin will be exhibiting in Exhibit Hall 3.2, Stand #115. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904119384/en/ Belkin announces new products at IFA 2025 Designed and developed at Belkin’s Global Headquarters in California, the latest product lineup reflects the brand’s hallmark commitment to safety, performance, and usability. Belkin continues to deliver future-ready accessories that meet the evolving needs of today’s devices and consumers. Every Belkin mobile power device undergoes SmartProtect testing for uncompromising safety, while So

Aqara Showcases Next-Gen Smart Homes Powered by Spatial Intelligence at IFA 20254.9.2025 09:00:00 CEST | Press release

Aqara, a global leader and pioneer in IoT, is poised to reveal its latest innovations in smart home technology at IFA 2025, showcasing a range of new solutions designed to enhance security, comfort, and energy efficiency by leveraging ubiquitous sensors and AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904310919/en/ Aqara Showcases Next-Gen Smart Homes Powered by Spatial Intelligence at IFA 2025 “At Aqara, we see spatial intelligence as the next frontier in smart home technology, and we’re proud to be at the forefront of this evolution,” said Cathy You, Senior Vice President of Global Business and Strategy at Aqara. “Our demonstrations at IFA highlight how advanced sensing, AI-driven insights, and contextual automation work together to deliver smarter environments—whether in residential homes, office buildings, hotels, retail spaces, or public facilities—that not only respond to user commands but also anticipate and

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline4.9.2025 07:00:00 CEST | Press release

Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval Strategic partnership with Biocodex in biotherapeutics development and manufacturing adds significant non-dilutive funding in addition to the Series B financing Investment fuels expansion of proprietary CORAL® platform and pipeline MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by French pharmaceutical group Biocodex and included strong participation from German-based ATHOS, as well as new investor BNP Paribas Fortis Private Equity and existing investors SFPIM, Ackermans & van Haaren (AvH), OMX Europe Venture Fund (OMX), Qbic II and VIB. Validation of Leadership Position in Microbiome-Based Therapeutics Proceeds will enable MRM Heal

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye